Take Heart in Primary Care Study
A cluster randomised controlled trial designed to investigate the impact on the prevalence and severity of depression, in patients with chronic manifestations of ischaemic heart disease.
NHMRC
604 participants
Sep 18, 2006
Interventional
Conditions
Summary
Heart disease is Australia's biggest health problem, affecting nearly 3.7 million people every year. Recent research has shown that emotional problems such as depression can make heart problems worse. However, it is often difficult to diagnose depression in people with heart problems. This research aims to improve the general health and wellbeing of people with chronic heart problems and depression by determining whether a special general practitioner enhanced education program, comprising the monitoring of depression, academic detailing of best-practice guidelines and psychiatric advice to the treating GP, will reduce depression in people with chronic heart probalems.
Eligibility
Exclusion Criteria1
- (Patients):a psychotic illness or communication deficit precluding communication with the GP, planned correction of underlying cardiovascular disease state (eg coronary artery bypass grafting or heart transplant) or acute hospital admission for any cardiovacular reason in past 3 months.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
A comprehensive three-part program of: 1)screening for depression in primary care patients requiring ongoing management of chronic manifestations of ischaemic heart disease; 2) academic detailing of best-practice guidelines for managing depression; and 3) patient-specific psychiatric advice to the treating GP with follow-up screening and advice, relative to usual GP management. Duration of study: 12 months. Depression will be determined via the Centre for Epidemiologic Studies-Depression Scale (CES-D) and the Arroll (2 question) scale. All study patients will be screened at baseline and 12 months. Patients in the intervention group, and depressed, will be rescreened at 3, 6 and 9 months as required.
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12606000371594